Klaria Pharma to Present at BioStock Life Science Spring Summit 2022 on June 8th
UPPSALA, 3 June, 2022. Klaria Pharma AB (Nasdaq Stockholm: KLAR) announces today that the company‘s CEO, Jesper Wiklund, will participate at the BioStock Life Science Spring Summit 2022 on June 8th and present Klaria Pharma.
Klaria Pharma’s presentation will start at 14:00/2 pm CET.
Follow the event online here: https://youtu.be/RmhNVEZSCww
For additional information please contact:
Investor Relations, Klaria Pharma AB
Tel: +46 (0)8 446 42 99, e-mail: investor.relations@klaria.com
This is Klaria Pharma Holding AB
Klaria (Klaria Pharma Holding AB) is a Swedish listed pharmaceutical company that develops innovative, rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, the company has developed a drug distribution concept with many benefits and potential uses. Klaria is listed on Nasdaq First North Growth Markets under the short name KLAR. FNCA Sweden is Certified Advisor (info@fnca.se, +46(0) 8-528 00 399) for Klaria Pharma Holding AB. For more information, see www.klaria.com.